-
661
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
Published 2015-01-01“…Prostate Cancer…”
Get full text
Article -
662
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting
Published 2024-08-01“…**Background:** The use of androgen receptor signaling inhibitors, including apalutamide, in combination with androgen deprivation therapy is recommended for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). …”
Get full text
Article -
663
Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
Published 2025-01-01Subjects: “…Prostatic Neoplasms…”
Get full text
Article -
664
-
665
Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men
Published 2012-01-01“…Prostate Cancer…”
Get full text
Article -
666
-
667
The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study
Published 2013-01-01“…The endpoints were changes in International Prostate Symptom Scores (IPSS), IPSS-QOL, International Index of Erectile Function-5, Qmax prostate volume, and residual urine volume. …”
Get full text
Article -
668
-
669
-
670
Risk factors of urinary tract infection through demographic and laboratory markers among benign prostate hyperplasia patients: a single-center study
Published 2024-12-01“…Introduction: Prostate enlargement known as benign prostatic hyperplasia (BPH) increases the risk of infection in the urinary tract by obstructing or blocking the prostatic portion of the urethra. …”
Get full text
Article -
671
-
672
A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China
Published 2025-01-01Subjects: “…Metastatic castration-resistant prostate cancer…”
Get full text
Article -
673
-
674
3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
Published 2025-01-01Subjects: “…Clinically significant prostate cancer…”
Get full text
Article -
675
HYDRODISSECTION FOR PRESERVATION OF NEUROVASCULAR BUNDLE DURING RADICAL PROSTATECTOMY
Published 2016-12-01Subjects: Get full text
Article -
676
Establishment and application of nursing standard operating procedures for DVSS-Si robot-assisted laparoscopic radical prostatectomy
Published 2024-12-01Subjects: Get full text
Article -
677
-
678
Impact of Obesity on Perioperative and Clinical Outcomes After Robotic Assisted Radical Prostatectomy
Published 2025-01-01Subjects: Get full text
Article -
679
Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer.
Published 2024-01-01“…<h4>Methods and findings</h4>Patients ≥18 years with a diagnosis of very-low to favorable intermediate-risk prostate cancer followed by 3 urologic oncologists from 2010 through 2021. …”
Get full text
Article -
680
Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1/PI3K/Akt pathway
Published 2025-02-01“…Objective This study aimed to investigate the possible mechanism by which curcumin inhibits human prostate cancer (PCa) and castration-resistant prostate cancer (CRPC). …”
Get full text
Article